PAVM
PAVM
NASDAQ · Health Care

Pavmed Inc

$3.80
-0.05 (-1.30%)
As of Sep 28, 10:41 PM ET ·
Financial Highlights (FY 2026)
Revenue
835.6K
Net Income
4.72M
Gross Margin
-207.0%
Profit Margin
564.8%
Rev Growth
-42.8%
D/E Ratio
0.33
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin -207.0% -207.0% 44.0% 44.0%
Operating Margin -30,794.4% -27,714.9% 8.6% 7.3%
Profit Margin 564.8% 536.6% 6.6% 6.9%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 835.6K 1.46M 6.38M 6.70M
Gross Profit -1,730,088 -3,026,216 2.81M 2.95M
Operating Income -257,326,994 -405,097,594 548.6K 488.5K
Net Income 4.72M 7.43M 418.8K 465.2K
Gross Margin -207.0% -207.0% 44.0% 44.0%
Operating Margin -30,794.4% -27,714.9% 8.6% 7.3%
Profit Margin 564.8% 536.6% 6.6% 6.9%
Rev Growth -42.8% -42.8% +12.0% -1.1%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 3.76M 3.76M 2.13M 1.84M
Total Equity 11.51M 11.51M 6.09M 6.42M
D/E Ratio 0.33 0.33 0.35 0.29
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -256,081,728 -425,533,744 672.1K 715.5K
Free Cash Flow — — 349.1K 300.8K